Sir,

The recent letter from Bertozzi and Appignani on the topic of rabies immunisation is very interesting.\[[@ref1]\] Bertozzi *et al*. agreed with our previous report that "immunoglobulin should be based on the severity of the wound.\[[@ref2]\]" In addition, Bertozzi *et al*. raised two important considerations:

The problem on determination of wound severity and,The use of pre-exposure prophylaxis.

For the first issue, it is not a myth. Standard guideline for using of immunoglobulin can be available. The possible adverse effect of immunoglobulin is the issue that should be weight before using it. For the second issue, Bertozzi *et al*. discussed on the cost and availability of vaccine and immunoglobulin.\[[@ref1]\] It is no doubt that any vaccine or immunoglobulin cost. However, in term of cost-effectiveness, the lost due to no immunisation to the patient is significantly more. Hampson *et al*. confirmed that post-exposure prophylaxis for rabies is an actual cost-effective strategy.\[[@ref3]\] Focusing on the pre-exposure prophylaxis, it is not routinely recommended. In Thailand, where the dog borne rabies is highly prevalent, it is still not suggested. If Bertozzi *et al*. actually considered on the cost, the pre-exposure vaccination seems to be not cost-effective for both local people in endemic areas and travellers who visit those areas.\[[@ref4]\]
